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Evidence suggests that optimism may be protective for health during times of heightened stress, yet the
mechanisms involved remain unclear. In a double-blind placebo-controlled study, we recently showed
that acute psychological stress and an immune stimulus (Typhim-Vi typhoid vaccine) synergistically
increased serum levels of interleukin-6 (IL-6) and negative mood in 59 healthy men. Here we carried
out further analysis of this sample to investigate the relationship between dispositional optimism and
stress-induced changes in immunity and mood. Volunteers were randomly assigned to one of four exper-
imental conditions in which they received either typhoid vaccine or saline placebo, and then rested or
completed two mental tasks. In the stress condition, optimism was inversely related to IL-6 responses,
independent of age, BMI, trait CES-D depression and baseline IL-6. This relationship was present across
both stress groups (combining vaccine and placebo) and was not present in the vaccine/stress group
alone, suggesting that optimism protects against the inﬂammatory effects of stress rather than vaccine
per se. Typhoid vaccine induced a signiﬁcant increase in participants’ circulating anti-Vi antibody levels.
Stress had no effect on antibody responses overall. However, in the vaccine/stress group, there was a
strong positive association between optimism and antibody responses, indicating that stress accentuated
the antibody response to vaccine in optimists. Across the complete sample, more optimistic individuals
had smaller increases in negative mood and less reduction in mental vigour. Together these ﬁndings sug-
gest that optimism may promote health, by counteracting stress-induced increases in inﬂammation and
boosting the adjuvant effects of acute stress.
 2009 Elsevier Inc.Open access under CC BY-NC-ND license.1. Introduction
Dispositional optimism, deﬁned as the generalized expecta-
tion that good rather than bad things will occur in one’s life,
has been related to better psychological and physical well-being,
particularly during times of heightened stress (Scheier and Car-
ver, 1992; Smith and MacKenzie, 2006). Optimistic individuals
recover more quickly following cardiac-related events such as
coronary artery bypass surgery and myocardial infarction, with
a more rapid return to a normal lifestyle and a better reported
quality of life (Agarwal et al., 1995; Scheier et al., 1989). Opti-
mism also appears to be associated with lower levels of distress,
slower disease progression and improved survival rates in pa-
tients with HIV (Ironson and Hayward, 2008), and certain types
of cancer (Allison et al., 2003; Carver et al., 2005; de Moor et al.,
2006), and comparable protective effects of optimism on psycho-
logical and physical well-being have been reported in caregivers
(Hulbert and Morrison, 2006), undergraduate students adapting
to the ﬁrst college semester (Segerstrom et al., 1998), pregnant
women (Fontaine and Jones, 1997) and elderly people (Giltay-NC-ND license.et al., 2006a). In line with these ﬁndings, optimists have a signif-
icantly reduced risk of future cardiovascular as well as all-cause
mortality (Chida and Steptoe, 2008; Giltay et al., 2006b; Kubzan-
sky et al., 2001), an effect that is independent of traditional car-
diovascular risk and socio-demographic factors.
The mechanisms underlying the potential protective effect of
optimism on health remain unclear. Optimistic people tend to en-
gage in more positive health practices, with higher levels of phys-
ical activity, reduced levels of smoking and alcohol consumption,
and a healthier diet (Scheier and Carver, 1992). They are also more
likely to adopt an active coping style when faced with adversity,
and less likely to engage in avoidant coping, a strategy related to
poorer long-term health (Taylor and Stanton, 2007). Furthermore,
optimism is inversely correlated with negative personality charac-
teristics such as neuroticism, anxiety and depression that are
themselves related to poorer mental and physical health. However,
despite their recognised contribution to the protective effects of
optimism, the relationship between optimism and health persists
after controlling for these factors, indicating that other pathways
are involved.
One such pathway could be the immune system. Chronic stress
is associated with dysregulated immunity and an increased
susceptibility to cancer, autoimmune and inﬂammatory disease
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that optimism can moderate the negative impact of stress on
immunity. For example, during situations of academic stress that
are commonly accompanied by reduced lymphocyte levels and
function, students scoring high on optimism display greater num-
bers of cytotoxic T cells, improved natural killer cell (NKC) activity
and larger antigen-stimulated delayed-type hypersensitivity re-
sponses than students with low optimism scores (Segerstrom
et al., 1998; Segerstrom, 2001, 2005). Similarly, in women recently
diagnosed and surgically treated for breast cancer, high levels of
dispositional optimism were found to counteract the association
between perceived stress and lowered NKC activity (Von Ah
et al., 2007). However, the relationship between optimism and
immunity is complex and dependent on the duration and type of
stressor involved, and not all studies report a protective effect of
optimism on stress-induced immune changes (Cohen et al.,
1999a; Segerstrom, 2001, 2005). Furthermore, little is known
about the potential effect of optimism on other stress-sensitive im-
mune molecules such as cytokines and antibodies.
The inﬂammatory cytokine, interleukin-6 (IL-6) plays a key
role in infectious and inﬂammatory disease (Naugler and Karin,
2008). Circulating levels of IL-6 are increased during immune
activation, and correlate with infection-related somatic and
depressive symptoms in humans and animals exposed to bacte-
rial or viral pathogens (Cohen et al., 1999b; Dantzer et al., 2008;
Reichenberg et al., 2001; Wright et al., 2005). Notably, psycho-
logical stress also increases circulating IL-6 (Steptoe et al.,
2007), and acute psychosocial stressors were found to upregulate
cytokine and behavioural responses to immune stimuli in ro-
dents (Gandhi et al., 2007; Gibb et al., 2008). We recently carried
out a double-blind, randomized, placebo-controlled study to
examine whether acute psychological stress might have a similar
effect on inﬂammatory cytokine and mood responses to an im-
mune stimulus in humans (Brydon et al., 2009). In that study,
healthy men were assigned to one of four experimental condi-
tions in which they received typhoid vaccine or saline placebo
and then either rested or completed two challenging behavioral
tasks. Tasks induced signiﬁcant increases in participants’ subjec-
tive stress ratings, systolic BP, diastolic BP and heart rate, with
no differences between vaccine and placebo conditions. Typhoid
vaccine but not placebo induced a signiﬁcant increase in partic-
ipants’ serum levels of IL-6, and this response was larger in the
stress compared to rest conditions, indicating that stress accen-
tuated the IL-6 response to vaccine. Total negative mood, as-
sessed using the Proﬁle of Mood States questionnaire,
increased immediately following stress tasks, an effect also more
pronounced in the vaccine/stress versus placebo/stress condition.
Together, these ﬁndings suggested that, similar to observations
in animals, psychological and immune stressors may act syner-
gistically to promote inﬂammation and sickness behavior in hu-
mans (Brydon et al., 2009). In the current investigation, we
carried out additional analyses of the same sample to examine
the relationship between dispositional optimism and changes
in IL-6 and negative mood following exposure to acute psycho-
logical stress and typhoid vaccine. We hypothesised that opti-
mism would exert a protective effect by attenuating the
synergistic and/or individual effects of psychological and im-
mune stressors on IL-6 and negative mood in men. We also
examined the potential association between optimism, psycho-
logical stress and antibody responses to the vaccine. Previous re-
ports have shown that acute psychological stress accentuates
antibody responses to other types of vaccines including inﬂuenza
and Meningococcal A vaccine in humans (Edwards et al., 2006,
2008). We predicted that acute stress would enhance antibody
responses to typhoid vaccine and that optimism would promote
this effect.2. Methods
2.1. Participants
Fifty-nine male volunteers were recruited for the study, the de-
tails of which are reported elsewhere (Brydon et al., 2009). All par-
ticipants gave their informed consent and the study was approved
by the joint UCL/UCLH Committee on the Ethics of Human Re-
search. Participants were students at University College London,
aged between 18 and 30 years, and were screened by structured
interview to ensure that they were healthy, had no previous his-
tory of any relevant physical or psychiatric illness, were taking
no medication and were non-smokers. They were instructed not
to take antibiotics, aspirin or ibuprofen for 14 days prior to testing,
and to avoid caffeinated beverages, alcohol and excessive exercise
during the 12 h prior to testing. Volunteers who had received ty-
phoid vaccine in the past 3 years or any other vaccine in the previ-
ous 6 months were excluded.
2.2. Immune stimulus
Salmonella typhi capsular polysaccharide vaccine (Typhim-Vi,
Aventis Pasteur) was used as an immune stimulus. This vaccine
is a thymus-independent type 2 antigen (Kroon et al., 1999) previ-
ously shown by our group and others to increase circulating levels
of cytokines and induce negative mood states in healthy volunteers
(Strike et al., 2004; Wright et al., 2005). Unlike other infection
models, it is a relatively mild inﬂammatory stimulus and does
not provoke fever or feelings of malaise that could potentially con-
found responses measured.
2.3. Psychological measures
Dispositional optimism was assessed using the revised version
of the Life Orientation Test (LOT-R), a 10-item self report question-
naire that evaluates generalised expectations of positive and nega-
tive outcomes (Scheier et al., 1994). Participants were asked to
indicate the extent of their agreement with each item from 0
(strongly disagree) to 4 (strongly agree). Only six items are used to
derive an optimism score (four are ﬁller items). Thus, potential
scores ranged from 0 to 24, with higher scores indicating higher
levels of optimism. Mood and symptoms of illness were assessed
with a modiﬁed 36-item version of the Proﬁle of Mood States
(POMS), as described previously (Brydon et al., 2009; McNair
et al., 1981). Six high-loading items were taken from the vigour,
tension–anxiety, depression–dejection, and confusion scales of
the original POMS, and ﬁve items were taken from the fatigue
scale. Four extra items were added to assess symptoms associated
with mild infection (fever, aching joints, nausea, and headache).
Participants were asked to rate how they felt at that moment on
a 5-point scale from 0 = not at all to 4 = extremely. Total mood
score was calculated (as recommended in the POMS manual) by
summing all negative items (tension, depression, confusion and fa-
tigue). Overall mood scores could range from 0 to 96, with higher
scores indicating a more negative mood. Depression was assessed
by the Centre for Epidemiological Studies Depression (CES-D)
Scale, a widely used self-report questionnaire (Radloff, 1977).
Scores could range from 0 to 60, with higher scores indicating more
depressed mood.
2.4. Immune measures
Circulating concentrations of interleukin-6 (IL-6) were assessed
in serum. Whole blood samples (10 ml) were drawn using a 21-
gauge butterﬂy needle into a serum-separator vacutainer tube
(BD Vacutainer Systems, Oxford, UK) and left upright to clot for
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room temperature and serum was removed, aliquoted and stored
at 80 C prior to analyses. Serum IL-6 concentrations were as-
sessed in duplicate samples by a high sensitivity two-site en-
zyme-linked immunosorbent assay (ELISA) from R and D Systems
(Oxford, UK). The detection limit of this assay was 0.09 pg/ml, with
intra- and inter-assay coefﬁcients of variation (CVs) of 4.69% and
4.66%, respectively.
Antibodies speciﬁc for S. typhi capsular polysaccharide vaccine
(anti-Vi antibodies) were assessed in plasma. Whole blood samples
(10 ml) were drawn using a 21-gauge butterﬂy needle into an
EDTA-vacutainer tube (BD Vacutainer Systems, Oxford, UK), then
centrifuged immediately at 1250g for 10 min at room temperature.
Plasma was removed, aliquoted and stored at 80 C prior to anal-
yses. Anti-Vi antibodies were measured using an ELISA developed
at the Laboratory of Enteric Pathogens, Health Protection Agency
in London, UK as described previously (Chart et al., 2007).
2.5. Cardiovascular and neuroendocrine measures
Blood pressure and heart rate were assessed throughout the
session using a Portapres-2, a portable version of the Finapres con-
tinuous BP monitoring device that shows good reproducibility and
accuracy in a range of settings (TNO-TPD Biomedical Instrumenta-
tion, Amsterdam, Holland). Saliva samples were collected using
Salivettes (Sarstedt Inc., Leicester, UK) and stored at 80 C prior
to analyses. Salivary cortisol was measured in duplicate samples
by an ELISA (SLV-2930, DRG International, Inc., USA) at Kurume
University in Japan. This assay had a detection limit of 0.53 ng/ml,
and intra- and inter-assay CVs of 2.61% and 3.63%, respectively.
2.6. Procedure
Details of this laboratory testing procedure have been reported
previously (Brydon et al., 2009). The investigation was carried out
in a double-blind, randomised, placebo-controlled manner. All
sessions commenced at 09:00 and participants were assessed
individually. Anthropometric measures were obtained using
standardised methods and a baseline blood sample was drawn
by separate venepuncture for assessment of basal circulating lev-
els of IL-6 and anti-Vi antibodies. Participants were then ran-
domly assigned to one of four experimental conditions (15
vaccine and stress; 15 placebo and stress; 14 vaccine and rest;
15 placebo and rest), by an investigator who had no involvement
in participant testing. A trained nurse or clinician administered
injections of either S. typhi capsular polysaccharide vaccine
(0.025 mg in 0.5 ml, Typhim Vi, Aventis Pasteur, MD) or control
saline placebo (0.5 ml) intramuscularly into the non-dominant
deltoid muscle at approximately 09:45. Finger cuffs were ﬁtted
so that blood pressure and heart rate could be monitored using
the Portapres-2, and participants were left to rest for 30 min.
Blood pressure and heart rate were recorded for the last 5 min
of the rest period, and a saliva sample was obtained for assess-
ment of cortisol. Participants then either continued to rest or
completed two challenging mental tasks, each lasting 5 min. They
were not told whether they would rest or perform tasks until this
time point. The ﬁrst was a computerized Stroop task, involving
the successive presentation of target color words printed in an
incongruous color. Participants were instructed to press a key
that corresponded to the position at the bottom of the screen of
the name of the color in which the target word was printed.
The second was a simulated public speaking exercise, in which
participants were presented with an imaginary scenario where
they had been wrongly accused of theft. They were instructed
to give a speech in their defense and told that their speech would
be video taped and subsequently assessed for efﬁcacy and ﬂu-ency. Five-minute recordings of blood pressure and heart rate
were made during each of the tasks and a second cortisol sample
was obtained immediately after the second task (approximately
10:45). Participants then rested quietly for the remainder of the
session. They were asked to rate subjective feelings of stress on
a 7-point scale from 1 = low to 7 = high at baseline (towards the
end of the rest period), following each of the tasks and then at
30, 60 and 120 min post-task. Ratings of task difﬁculty, controlla-
bility and involvement were also made after each task on 7-point
scales. Further recordings of blood pressure and heart rate were
made at 25–30 min, 55–60 min and 115–120 min post-tasks and
saliva samples were obtained at 15, 30, 60 and 120 min post-
tasks. Subjective ratings of mood and illness symptoms were also
obtained at baseline, immediately post-tasks, and at 30, 60 and
120 min post-tasks, and body temperature was measured at these
time points using a sublingual digital thermometer. A second
blood sample was drawn by separate venepuncture at 120 min
post-tasks (corresponding to 3 h post-vaccination) for assessment
of interleukin-6, and a third blood sample was obtained 3 weeks
post-vaccination for assessment of anti-Vi antibodies.
2.7. Statistical analyses
Background characteristics of participants in the four groups
were compared using analysis of variance for continuous vari-
ables, and v2-tests for categorical variables. Subjective and car-
diovascular responses to the experimental protocol were
analysed using repeated measures analysis of variance, with
group (vaccine/placebo and stress/rest) as between-person factors
and trial (baseline, Stroop, Speech, recovery 1 (30 min), recovery 2
(60 min) and recovery 3 (120 min)) as the within-person factor.
The repeated measures analysis of cortisol involved six trials
(baseline, task, and 15, 30, 60 and 120 min post-task), while the
analysis of serum IL-6 involved baseline and 120 min post-task
measures, and analyses of plasma anti-Vi antibodies involved
baseline and 3 week post-vaccination measures. The analyses of
mood responses included vaccine and stress grouping factors
and ﬁve trials (baseline, immediately post-task, and 30, 60 and
120 min post-task). The Greenhouse–Geisser correction of degrees
of freedom was applied when sphericity assumptions were vio-
lated, but raw degrees of freedom are presented in Section 3.
The distribution of serum IL-6 was skewed, so was log trans-
formed prior to analysis. Post hoc tests were conducted using Tu-
key’s least signiﬁcant difference (LSD) test. Associations between
responses and optimism were analysed by multiple linear regres-
sion. The covariates in the regressions on mood responses in-
cluded the baseline level of the mood variable, age and BMI,
while scores on the CES-D were added to the regressions on bio-
logical responses to account for background affect. Effect sizes for
optimism are represented by the change in r2 accounted for, over
and above the effect of covariates.
3. Results
Details of participant characteristics and general stress re-
sponses have been reported previously elsewhere (Brydon et al.,
2009). There were no signiﬁcant differences between the four
experimental groups in terms of age, BMI, or baseline levels of car-
diovascular activity, cortisol, immune measures or negative mood.
Participants’ dispositional optimism scores on the LOT-R ranged
from 2 to 22, with a mean score of 14.9, and there were no group
differences in optimism scores. Scores on the CES-D averaged
12.59 ± 7.7, and also did not differ between groups. Participants’
body temperature remained stable throughout the session and
none of the participants reported any appreciable somatic symp-
toms such as aching joints, headache or nausea.
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Fig. 2. Mean change in serum IL-6 concentrations (pg/ml, logged) at 120 min post-
stress in relation to quintiles of dispositional optimism score, across both stress
groups (vaccine/stress and placebo/stress conditions combined). Values are
adjusted for age, BMI, CES-D score and baseline serum IL-6 levels. Error bars are
SEM.
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Fig. 3. Mean plasma anti-Vi antibody values (quantiﬁed by OD405) before vaccina-
tion (Baseline) and 3 weeks following vaccination (3 weeks). Comparison of stress
(solid lines) and rest (dotted lines) conditions in participants receiving typhoid
vaccine (circles) or saline placebo (squares). Error bars are SEM.
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Across all four groups, optimism was associated with a smaller
increase in total negative mood at 30 min, controlling for baseline
negative mood, BMI and age (b = 0.29, SE = 0.13, p = 0.030, addi-
tional r2 = 0.044). This effect was signiﬁcant in the overall sample
only and did not vary between groups. Analysis of scores on the
POMS subscales showed that, in the complete sample, optimism
was associated with a larger increase in vigour at 30 min, control-
ling for baseline vigour, BMI and age (b = 0.34, SE = 0.13, p = 0.011,
additional r2 = 0.035) and with smaller increases in tension/anxiety
at both 30 min (b = 0.25, SE = 0.11, p = 0.026, additional
r2 = 0.075) and 60 min (b = 0.25, SE = 0.11, p = 0.032, additional
r2 = 0.071), controlled for baseline tension/anxiety, BMI and age.
The effect for tension/anxiety at 60 min is illustrated in Fig. 1
showing larger increases in tension/anxiety in people with lower
optimism scores, adjusted for covariates.
3.2. Optimism and IL-6 responses
Although stress alone had no overall effect on participants’ ser-
um IL-6 levels, there were large individual differences in the IL-6
response, ranging from a decrease of 0.72 pg/ml to an increase of
4.01 pg/ml at 2 h post-task in the placebo/stress group. Similarly,
IL-6 responses in the vaccine/stress group ranged from a decrease
of 0.56 pg/ml to an increase of 3.10 pg/ml at 2 h. Optimism was in-
versely related to IL-6 stress responses (b = 0.50, SE = 0.24,
p = 0.046, additional r2 = 0.158), independent of baseline IL-6 lev-
els, BMI, age and trait CES-D depression. This effect is illustrated
in Fig. 2 showing mean changes in serum IL-6 in relation to quin-
tiles of optimism score, adjusted for covariates. Notably, this rela-
tionship was present in the stress groups (combining vaccine and
placebo), and was not present in the vaccine/stress group alone,
suggesting that optimism moderates the inﬂammatory response
to psychological stress rather than vaccine per se. There was no
relationship between optimism and IL-6 measures in either of
the rest (vaccine/rest, placebo/rest) conditions (all p > 0.10).
3.3. Optimism and antibody responses
Participants who had received typhoid vaccine but not placebo,
had signiﬁcant increases in plasma levels of anti-Vi antibodies
3 weeks following vaccination (F(1.54) = 57.7, p < 0.001) (Fig. 3).
There was no signiﬁcant difference in the stress and rest conditions
in this response, suggesting that acute stress did not moderate the
antibody response to typhoid vaccine. However, in the vaccine/
stress group only, there was a strong positive association between0
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additional r2 = 0.463), independent of baseline antibody level, age
and BMI (Fig. 4). This effect was not present in any of the other 3
groups (b = 0.04 to +0.01, p > 0.40). Thus, in optimistic individu-
als, acute stress appears to accentuate antibody responses to ty-
phoid vaccine. When trait depression (CES-D score) was included
in the analysis, the relationship between optimism and antibody-0.2
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levels of anti-Vi antibodies at 3 weeks post-vaccination and dispositional optimism
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814 L. Brydon et al. / Brain, Behavior, and Immunity 23 (2009) 810–816response was weakened (b = 0.58, p = 0.081), suggesting that this
effect was partly dependent on the inverse correlation between
optimism and depressed mood (r = 0.65). Nevertheless, there
was no signiﬁcant association between CES-D scores themselves
and antibody responses (p = 0.42).
3.4. Optimism and subjective, cardiovascular and neuroendocrine
measures
There were no signiﬁcant associations between optimism and
subjective ratings of stress or task difﬁculty, involvement, or per-
ceived performance in either the vaccine/stress or placebo/stress
groups, and no signiﬁcant associations between optimism and
measures of systolic BP or heart rate in any of the groups. However,
in the vaccine/stress group, more optimistic individuals had signif-
icantly lower levels of diastolic BP at both 60 min (b = -0.80,
SE = 0.20, p = 0.004, additional r2 = 0.383) and 120 min (b = 0.71,
SE. = 0.22, p = 0.011, additional r2 = 0.300) post-stress, independent
of baseline DBP, age, BMI and CES-D score. The effect at 120 min is
illustrated in Fig. 5 (r = 0.70, p = 0.004). These associations were
not signiﬁcant in any other group (b = 0.102 to 0.116, all
p > 0.60). In the vaccine conditions (vaccine/stress and vaccine/rest
combined), there was also an inverse association between opti-
mism and cortisol levels at 120 min post-stress (b = 0.45,
SE = 0.20, p = 0.035, additional r2 = 0.097), independent of baseline
cortisol levels, age, BMI and CES-D score. This effect is illustrated in
Fig. 6, showing mean decreases in cortisol in relation to quintiles of
dispositional optimism score, adjusted for covariates. There was no
signiﬁcant association between optimism and cortisol levels in the
placebo groups (all p > 0.20).
4. Discussion
One of the main ﬁndings of our study was that participants with
high levels of dispositional optimism had smaller IL-6 responses in
the stress condition. This relationship was observed across both
stress groups (combining vaccine and placebo) but was not seen
in the vaccine/stress group alone, indicating that optimism pro-
tects against the inﬂammatory effects of psychological stress
rather than vaccine per se. Supporting this idea, a separate study
investigating the relationship between optimism and stress re-
sponses in temporomandibular disorder (TMD) patients, found
that optimistic patients had smaller plasma IL-6 levels during a
speech stressor compared to their pessimistic counterparts (Cos-
tello et al., 2002). Other studies have also related positive psycho--5
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salogical constructs to smaller stressor-induced increases in inﬂam-
matory markers. For example, positive affect was associated with
decreased production of IL-6 by LPS-stimulated human monocytes
in vitro (Prather et al., 2007) and smaller plasma ﬁbrinogen re-
sponses to acute psychological stress in civil servants from the
Whitehall II epidemiological cohort (Steptoe et al., 2005), and a
recent investigation found an inverse relationship between
self-esteem and inﬂammatory cytokine responses to acute
psychological stress in women (O’Donnell et al., 2008).
Reduced stress-induced increases in IL-6 may be a mechanism
through which optimism is protective for physical and mental
health. IL-6 plays a pivotal role in inﬂammation and immunity,
and circulating levels of this cytokine are elevated in a number of
inﬂammatory-type conditions known to be exacerbated by stress
including cardiovascular disease, arthritis, multiple sclerosis, asth-
ma, pain and certain types of cancers (Kemeny and Schedlowski,
2007; Naugler and Karin, 2008). Although few studies have ad-
dressed the clinical relevance of acute increases in IL-6, IL-6 re-
sponses to a single bout of laboratory stress have been related to
heightened pain sensitivity in TMD patients (Costello et al., 2002)
as well as predicting future increases in blood pressure in healthy
adults from the Whitehall 11 cohort (Brydon and Steptoe, 2005).
Experimental infection studies have also demonstrated a key role
for IL-6 in mediating illness symptoms. In adult volunteers exposed
to inﬂuenza A virus, high daily levels of perceived stress were asso-
ciated with elevated nasal concentrations of IL-6 and greater num-
bers of subjective and objective respiratory illness symptoms
(Cohen et al., 1999b). In that study, the IL-6 response to infection
was temporally related to both symptoms and mucus production,
suggesting that IL-6 was a major mechanism through which stress
exacerbated respiratory illness symptoms (Cohen et al., 1999b).
Similarly, and in line with our current results, a recent investiga-
tion found an inverse association between positive emotional style
and objective and subjective illness symptoms following rhinovi-
rus exposure in healthy adults, and showed that this relationship
was primarily driven by lower nasal levels of IL-6 (Doyle et al.,
2006).
Circulating IL-6 concentrations are also elevated in some pa-
tients with clinical depression, and correlate with depressive
symptoms in healthy individuals and patients with inﬂammatory
disease (Irwin and Miller, 2007). Endotoxin-induced elevations in
plasma IL-6 correlate with infection-related symptoms of anxiety
and depression in healthy volunteers (Reichenberg et al., 2001;
Wright et al., 2005), and there is substantial evidence that
peripheral cytokines can signal to the brain to inﬂuence mood
by altering neuroendocrine and neurotransmitter activity (Dant-
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ler increases in total negative mood during the testing session,
an effect primarily driven by lower levels of tension-anxiety
and larger increases in mental vigour in optimistic participants.
This ﬁnding is consistent with the well-established relationship
between optimism and improved psychological well-being (Sche-
ier and Carver, 1992), and suggests that smaller IL-6 responses in
optimists could be a mechanism protecting against stress-related
depressive illness. However, the observed associations between
optimism and mood were only signiﬁcant in the sample as a
whole, and we could not distinguish effects among the four
experimental groups. Furthermore, in the current study there
was no direct association between IL-6 responses and negative
mood. We are not sure of the reason for this, as we have previ-
ously found an association between IL-6 responses to typhoid
vaccine and negative mood in a separate sample of healthy vol-
unteers (Wright et al., 2005). However, the present study had a
more complex design and it is possible that a larger sample size
would be required to see these effects.
The other main study ﬁnding was that in participants ex-
posed to both typhoid vaccine and acute psychological stress,
there was a strong positive relationship between optimism and
anti-Vi antibody responses, suggesting that acute stress en-
hanced the antibody response to typhoid vaccine in optimistic
individuals. Acute psychological or physical stress at the time
of vaccination has been shown to boost antibody responses to
a number of other vaccines in humans. In healthy university stu-
dents, time-pressured mental arithmetic or exercise stress
administered prior to vaccination was found to improve anti-
body responses to inﬂuenza vaccine in women (Edwards et al.,
2006, 2007), and a recent study showed that antibody responses
to Meningococcal A vaccine were enhanced by exercise and
mental stress in men (Edwards et al., 2008). Stress-induced
enhancement of the immune response to infection is also ob-
served in animals, and is considered an evolutionary adaptive
mechanism designed to promote survival during times of height-
ened adversity such as wounding due to a predator-prey
encounter (Dhabhar, 2002). In the present investigation, we did
not see any effect of acute stress on antibody responses in our
overall sample, but rather only in more optimistic individuals.
Edwards and colleagues noted that the adjuvant effects of acute
stress were most apparent when the immune response of control
participants was relatively poor (Edwards et al., 2006, 2007,
2008), and our control (vaccine/rest) group mounted a satisfac-
tory antibody response to typhoid vaccine. Furthermore, the de-
sign of our study was somewhat different, in that acute mental
stress was administered after rather than prior to vaccination.
However, it is also likely that personality plays a role in the rela-
tionship between vaccination, immunity and stress. Trait positive
affect has been related to enhanced antibody responses to hepa-
titis B vaccination in graduate students (Marsland et al., 2006),
and a recent investigation showed that elevated levels of dispo-
sitional optimism during cardiovascular exercise training were
positively associated with training-induced improvements in a
primary immune response to a novel antigen in older adults
(Grant et al., 2008).
The pathways mediating the relationship between optimism
and stress-induced immune changes are unclear. As reported
previously (Brydon et al., 2009), tasks induced signiﬁcant in-
creases in participants’ levels of subjective stress, systolic BP
and diastolic BP, with no difference between vaccine and placebo
conditions. Participants’ salivary cortisol levels decreased on
average over time, with no group differences. However, there
were large individual differences in this response, with some
participants showing increases in cortisol following tasks (Bry-
don et al., 2009). There were no signiﬁcant associations betweenoptimism and subjective ratings of tasks, indicating that opti-
mists did not appraise or engage in the tasks differently from
their counterparts. However, in the vaccine/stress group, opti-
mists had lower diastolic BP at 1 and 2 h post-stress, indicative
of a faster recovery in autonomic balance, and in both vaccine
groups, optimists had lower post-stress levels of salivary cortisol.
Catecholamines stimulate IL-6 production from adipocytes and
LPS-stimulated monocytes, through binding to b-adrenergic
receptors expressed on these cells (Johnson et al., 2005; Moham-
ed-Ali et al., 2001). Thus, improved recovery in autonomic ner-
vous activity could potentially mediate the smaller IL-6
responses in optimists. Similarly, excess cortisol exposure has
been associated with glucocorticoid resistance and dysregulated
immunity (Bauer, 2005; Miller et al., 2002), and it is conceivable
that optimism could inﬂuence immune responses by attenuating
stress-induced changes in cortisol. In addition, IL-6 plays a key
role in linking innate and adaptive immunity (Naugler and Karin,
2008), and there is evidence that it can promote antibody re-
sponses to certain pathogens. For example, co-administration of
the IL-6 gene with DNA-based inﬂuenza vaccine completely pro-
tected mice from a subsequently lethal challenge with the virus
(Lee et al., 1999) and stress-induced increases in IL-6 measured
at the time of inﬂuenza vaccination were a signiﬁcant predictor
of antibody responses to the vaccine in women (Edwards et al.,
2006). However, other studies found no association between
IL-6 stress responses and antibody responses to other types of
vaccine in humans (Edwards et al., 2008), and in the current
investigation IL-6 responses were unrelated to anti-Vi antibody
measures (data not shown). Furthermore, optimistic individuals
had smaller IL-6 stress responses yet larger anti-Vi antibody re-
sponses in the vaccine/stress condition. These ﬁndings suggest
that optimism may inﬂuence these immune molecules though
distinct pathways.
This investigation was carried out in a sample of healthy male
university students, and results may not generalize to other pop-
ulations. Findings represent secondary analyses of a study with a
relatively small number of participants per group that was not
originally designed to test the primary hypothesis i.e. that opti-
mism protects against the harmful effects of stress. It is thus
conceivable that a larger sample size, including participants with
a wider range of dispositional optimism scores, may have gener-
ated more striking results. We did not include a coping measure,
and it would be useful to know whether coping style mediated
the beneﬁcial effects of optimism on stress responses. The
cross-sectional design limits conclusions about causality, and it
should be noted that peripheral cytokines can feedback to the
central nervous system to inﬂuence cognitive and affective func-
tion (Dantzer et al., 2008), so that IL-6 could potentially affect
optimistic mood. Supporting this, higher daily production of na-
sal mucus IL-6 in healthy adults exposed to rhinovirus or inﬂu-
enza was associated with a decline in concurrent daily positive
affect but unrelated to changes in negative affect (Janicki-De-
verts et al., 2007). Nevertheless, our ﬁndings suggest that trait
optimism may be protective for physical and mental health by
counteracting stress-induced increases in inﬂammation and
boosting the adjuvant effects of acute stress. These mechanisms
may help to explain why people with ‘a generalized tendency to
look on the bright side of things’ live a longer and healthier
life.
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